MRK vs PFE
By Alex · Tickerpine
Merck & Co., Inc. vs Pfizer Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | PFE |
|---|---|---|
| Price | $128.66 | $24.29 |
| Market cap | $317.77B | $138.44B |
| P/E ratio | 36.2 | 18.5 |
| ROE | 18.94% | 8.31% |
| Profit margin | 13.59% | 11.83% |
| Revenue growth | 4.90% | 5.40% |
| Dividend yield | 2.64% | 7.08% |
| Beta | 0.22 | 0.29 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs PFE in plain English
- MRK is the bigger company — about 2.3× the market cap of PFE.
- PFE is cheaper on earnings (P/E 18.5 vs 36.2).
- MRK earns a higher return on equity (19% vs 8%).
- PFE is growing revenue faster (5% vs 5%).
- PFE has the higher dividend yield (7.08% vs 2.64%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
PFE return calculator
See what $1,000 in Pfizer Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.